FINLAND: ACTIONS TO REDUCE PHARMACEUTICAL EMISSIONS IN THE BALTI SEA REGION

June 21 – Hundreds of different medicines are consumed in the Baltic Sea region daily. Medicines benefit human and animal health,but after the use many of them end up to environment and can cause adverse effects to wildlife. CWPharma project worked for over three years to gather and produce data on the consumption of pharmaceuticals and their concentrations in the environment, to identify the most problematic pharmaceutical compounds and to find the best ways to decrease their emissions to the environment.

The project ran from October 2017 to December 2020. The consortium consisted of 15 organisations, from seven countries in the Baltic region: Denmark, Estonia, Finland, Germany, Latvia, Poland, and Sweden. Its work is co-ordinated by the Finnish Environment Institute (SYKE). More information:

  • CWPharma Project website
  • CWPharma Project: Executive Summary of Political Action Plan.pdf
  • Executive Summary of Political Action Plan in other languages (Danish, Estonian, Finnish, Latvian, Polish, Swedish
  • CWPharma project story on Inrerreg Baltic website
  • CWPharma 2 project information: Link to Research Gat

Members’ Menu

(appears here when logged in)
Subscribe To the ISCO Newsletter
We promise not to spam you. Unsubscribe at any time.
Invalid email address

Download the latest Newsletters